# A Study of Staccato Loxapine (ADASUVE®) for Inhalation

> **NCT04148963** · PHASE3 · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 150 (estimated)

## Conditions studied

- Psychomotor Agitation
- Schizophrenia
- Bipolar Disorder

## Interventions

- **DRUG:** Inhaled loxapine
- **DRUG:** Inhaled placebo

## Key facts

- **NCT ID:** NCT04148963
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04148963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04148963, "A Study of Staccato Loxapine (ADASUVE®) for Inhalation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04148963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*